GB812138A - Improvements relating to antibiotic composition - Google Patents

Improvements relating to antibiotic composition

Info

Publication number
GB812138A
GB812138A GB17539/55A GB1753955A GB812138A GB 812138 A GB812138 A GB 812138A GB 17539/55 A GB17539/55 A GB 17539/55A GB 1753955 A GB1753955 A GB 1753955A GB 812138 A GB812138 A GB 812138A
Authority
GB
United Kingdom
Prior art keywords
magnesium
antibiotic
ions
source
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17539/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB812138A publication Critical patent/GB812138A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An intramuscularly acceptable antibiotic composition comprises tetracycline or oxytetracycline or their acid or basic salts, a soluble source of magnesium ions, a soluble source of absorption-enhancing non-toxic acid ions which source is solid in the dry state, and a non-toxic local an sthetic. The source of absorption-enhancing ions may be a water-soluble non-toxic carboxylic or thiocarboxylic acid or a lactone of such acids including citric, ascorbic, gluconic and thioglycollic acids or may be a soluble mineral acid salt of an amino acid. The antibiotic may be used in salt form as the hydrochloride, hydrobromide, sulphate, nitrate, citrate, ascorbate or gluconate, or as the sodium, potassium, ammonium, calcium, or magnesium salts as well as in the neutral form. The magnesium source may be a soluble ionizable salt such as the halides and their hydrates, e.g. magnesium chloride hexahydrate, or magnesium sulphate, nitrate, bromide, acetate, glycinate or as the magnesium salt of one of the absorption enhancing acids such as magnesium citrate or ascorbate. Specified local an sthetics include procaine, xylocaine, hydroxy-procaine, 2-chloroprocaine, piperocaine, hexylcaine, diethoxin, tetracaine and larocaine. They may be used as the free base or more conveniently as the hydrochlorides. The compositions may be prepared as a sterile, dry powder to which water may be added immediately prior to use, or alternatively one or more of the storage stable constituents may be present in the aqueous diluent. The components may be mixed and sterilized by ethylene oxide or if desired by high frequency radiation or by neutrons. The final composition should preferably contain 10 to 100 milligrams/millilitre of antibiotic calculated as antibiotic hydrochloride, an amount of an sthetic equivalent in effect to that obtained from 0.5 to 40 milligrams/millilitre, from 1 to 15 milligrams/millilitre of magnesium ions and the absorption-enhancing ions in an amount equal to up to three times that of the antibiotic. In an example, tetracycline hydrochloride, anhydrous citric acid and procaine hydrochloride are ground together and sterilized by exposure to ethylene oxide. Heated ground magnesium chloride hexahydrate is added and the mixture filled into glass vials. Reference has been directed by the Comptroller to Specification 739,736.
GB17539/55A 1954-06-17 1955-06-17 Improvements relating to antibiotic composition Expired GB812138A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US812138XA 1954-06-17 1954-06-17

Publications (1)

Publication Number Publication Date
GB812138A true GB812138A (en) 1959-04-22

Family

ID=22162786

Family Applications (1)

Application Number Title Priority Date Filing Date
GB17539/55A Expired GB812138A (en) 1954-06-17 1955-06-17 Improvements relating to antibiotic composition

Country Status (2)

Country Link
GB (1) GB812138A (en)
MY (1) MY6100085A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084802B2 (en) 2010-05-12 2015-07-21 Rempex Pharmaceuticals, Inc. Tetracycline compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084802B2 (en) 2010-05-12 2015-07-21 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US9278105B2 (en) 2010-05-12 2016-03-08 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US9744179B2 (en) 2010-05-12 2017-08-29 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US11944634B2 (en) 2010-05-12 2024-04-02 Melinta Subsidiary Corp. Tetracycline compositions

Also Published As

Publication number Publication date
MY6100085A (en) 1961-12-31

Similar Documents

Publication Publication Date Title
GB910450A (en) Improvements in or relating to alkali metal silicate compositions
GB770007A (en) Antiperspirant compositions
GB1066192A (en) Improvements in or relating to silicate grout
GB812138A (en) Improvements relating to antibiotic composition
ES8506193A1 (en) Bone-seeking complexes of technetium-99m.
ES344578A1 (en) Cold water-soluble eucheuma gel mixtures
GB1062438A (en) Improvements in or relating to soil stabilisation compositions
US4666710A (en) Anti-perspirant compositions
US3128227A (en) Antibiotic intramuscular composition
ES391536A1 (en) Procedure for obtaining antibacterial compositions. (Machine-translation by Google Translate, not legally binding)
GB827580A (en) Injectable tetracycline compositions
US2230211A (en) Plastic composition
GB662413A (en) Improvements in or relating to method of preparing an iodine containing benzoic acidand the product resulting therefrom
GB794798A (en) Pharmaceutical compositions
ES201713A1 (en) Improved cadmium halophosphate phosphors
GB727454A (en) Improvements in or relating to mixtures containing common salt intended for household purposes, and processes for producing same
GB719295A (en) Improvements in or relating to therapeutic procaine penicillin compositions
GB956360A (en) A pharmaceutical composition for use as a contraceptive and process for making same
GB1180252A (en) Stimulant Composition for Administration to Animals
GB343636A (en)
US2536315A (en) Vasoconstrictor antiseptic
GB967319A (en) Compositions for the sterilisation of soil
GB868601A (en) Tetracycline antibiotic compositions
ES393894A1 (en) Piperidinemethyl ethers
GB664997A (en) Pharmaceutical compositions